2012-10-05 16:56:56 - Fast Market Research recommends "Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2012" from Global Markets Direct, now available

Global Markets Direct's, 'Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Peripheral Neuropathy (Sensory Neuropathy), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Peripheral Neuropathy (Sensory Neuropathy). Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
- www.fastmr.com/prod/468415_peripheral_neuropathy_sensory_neuropa ..


Note*: Certain

sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Peripheral Neuropathy (Sensory Neuropathy).
* A review of the Peripheral Neuropathy (Sensory Neuropathy) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Peripheral Neuropathy (Sensory Neuropathy) pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Peripheral Neuropathy (Sensory Neuropathy).
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Peripheral Neuropathy (Sensory Neuropathy) pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Peripheral Neuropathy (Sensory Neuropathy) Overview
Therapeutics Development
An Overview of Pipeline Products for Peripheral Neuropathy (Sensory Neuropathy)
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics under Development by Companies
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics - Products under Development by Companies
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Development
NsGene A/S
Neuren Pharmaceuticals Limited
NeurogesX, Inc.
Allon Therapeutics Inc.
Peripheral Neuropathy (Sensory Neuropathy) - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
capsaicin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AL-309 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
NNZ-2591 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
NsG-31 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
amifostine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Amitriptyline + Ketamine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
glutamine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Carboplatin + Glutathione + Paclitaxel - Drug Profile
Product Description
Mechanism of Action
R&D Progress
thioctic acid [JAN] - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Immunoglobulin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
flupirtine maleate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics - Drug Profile Updates
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics - Discontinued Products
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics - Dormant Products
Peripheral Neuropathy (Sensory Neuropathy) - Product Development Milestones
Featured News & Press Releases
Nov 17, 2011: Pfizer Obtains European Approval For Vyndaqel For Transthyretin Familial Amyloid Polyneuropathy
Feb 09, 2011: CeNeRx Receives FDA IND Approval For CXB909
Feb 07, 2011: EpiCept Reports Positive Results From EpiCept NP-1 Trial In Patients With Chemotherapy-Induced Peripheral Neuropathy
Sep 08, 2010: DARA Announces Phase III Trial Results Of KRN5500 In Patients With Chemotherapy Induced Peripheral Neuropathy And Advanced Cancer
Jun 11, 2010: Pfizer, Eisai to launch postherpetic neuralgia drug Lyrica Capsules on June 22

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468415&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.